General Biologicals Corporation announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was TWD 125.561 million compared to TWD 123.054 million a year ago. Operating loss was TWD 18.483 million compared to TWD 19.724 million a year ago. Net loss was TWD 20.786 million compared to TWD 21.624 million a year ago. Basic loss per share was TWD 0.53 compared to TWD 0.55 a year ago.